Skip to content

Drug interactions

Ifosfamide + Trabectedin

Severity: Moderate

Ifosfamide and Trabectedin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both ifosfamide and trabectedin can cause cardiomyopathy, and trabectedin additionally causes hepatotoxicity and myelosuppression. Combined use can increase the risk of reduced cardiac function and of cytopenias.

What this interaction means in plain words

Ifosfamide and Trabectedin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ifosfamide belongs to Oncology; Trabectedin belongs to Oncology.

Evidence level: Low

Why it happens

Additive cardiotoxicity and myelosuppression.

What to do

Assess left ventricular ejection fraction before and periodically during therapy, and monitor liver enzymes and blood counts. Stop or reduce trabectedin if cardiac function declines.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ifosfamide and Trabectedin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ifosfamide with Trabectedin?

MediHelp rates the interaction as moderate. Ifosfamide and Trabectedin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both ifosfamide and trabectedin can cause cardiomyopathy, and trabectedin additionally causes hepatotoxicity and myelosuppression. Combined use can increase the risk of reduced cardiac function and of cytopenias.

How serious is the interaction between Ifosfamide and Trabectedin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Assess left ventricular ejection fraction before and periodically during therapy, and monitor liver enzymes and blood counts. Stop or reduce trabectedin if cardiac function declines.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in